
#Industry News
Firalis is partnering with Institut de recherche en hématologie et transplantation (IRHT) on the DiaBioLiq Research Project to improve brain cancer diagnosis.
Towards better patient care and management
Firalis is partnering with Institut de recherche en hématologie et transplantation (IRHT) on the DiaBioLiq Research Project to improve brain cancer diagnosis.
"DiaBioLiq" - Diagnostic via Liquid Biopsy, is an innovative project seeking to simplify brain cancer detection without invasive biopsies, minimizing patient risks. Leveraging cerebrospinal fluid samples obtained through lumbar puncture, DiaBioLiq promises a safer and more accessible diagnostic approach.
Firalis will contribute to the project with its expertise in developing high-quality diagnostic kits.